Cardioprotective Drugs and Diagnostics for Assessing Risk of Cardiovascular Disease
AssigneeMUSC Foundation for Research Development
InventorsKelley M. Argraves, W. Scott Argraves, Alan T. Remaley, Amar Sethi
Life of this patent
Estimating the term…
Abstract
Disclosed are methods of diagnosing cardiovascular disease comprising measuring sphingolipids. Also disclosed are methods of predicting cardiovascular disease comprising measuring sphingolipids. Also disclosed are methods of identifying subjects at risk of developing cardiovascular disease comprising measuring sphingolipids.
Claims20
A method of diagnosing cardiovascular disease in a subject, comprising the steps of:
- a. collecting body fluid from the subject;
- b. measuring the level of at least one sphingolipid in the body fluid;
- c. diagnosing cardiovascular disease in a subject based on the measured level of sphingolipids.
A method of predicting cardiovascular disease in a subject, comprising the steps of:
- a. collecting body fluid from the subject;
- b. measuring the level of at least one sphingolipid in the body fluid;
- c. predicting cardiovascular disease in a subject based on the measured level of sphingolipids.
A method of identifying a subject at risk of developing cardiovascular disease in a subject, comprising the steps of:
- a. collecting body fluid from the subject;
- b. measuring the level of at least one sphingolipid in the body fluid;
- c. identifying a subject at risk of developing cardiovascular disease based on the measured level of sphingolipids.
A method of treating cardiovascular disease in a subject, comprising administering a composition elevating sphingolipid levels in a subject.
Dependencies are inferred from the claim text.